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Abstract
Background Near-infrared imaging with indocyanine
green (ICG) has been extensively investigated during
laparoscopic cholecystectomy (LC). However, methods
vary between studies, especially regarding patient selec-
tion, dosage and timing. The aim of this systematic review
was to evaluate the potential of the near-infrared imaging
technique with ICG to identify biliary structures during LC.
Methods A comprehensive systematic literature search
was performed. Prospective trials examining the use of
ICG during LC were included. Primary outcome was bil-
iary tract visualization. Risk of bias was assessed using
ROBINS-I. Secondly, a meta-analysis was performed
comparing ICG to intraoperative cholangiography (IOC)
for identification of biliary structures. GRADE was used to
assess the quality of the evidence.
Results Nineteen studies were included. Based upon the
pooled data from 13 studies, cystic duct (Lusch et al. in J
Endourol 28:261–266, 2014) visualization was 86.5%
(95% CI 71.2–96.6%) prior to dissection of Calot’s triangle
with a 2.5-mg dosage of ICG and 96.5% (95% CI
93.9–98.4%) after dissection. The results were not
appreciably different when the dosage was based upon
bodyweight. There is moderate quality evidence that the
CD is more frequently visualized using ICG than IOC (RR
1.16; 95% CI 1.00–1.35); however, this difference was not
statistically significant.
Conclusion This systematic review provides equal results
for biliary tract visualization with near-infrared imaging
with ICG during LC compared to IOC. Near-infrared
imaging with ICG has the potential to replace IOC for
biliary mapping. However, methods of near-infrared
imaging with ICG vary. Future research is necessary for
optimization and standardization of the near-infrared ICG
technique.
Keywords Near-infrared imaging  ICG  Laparoscopic
cholecystectomy  Biliary tract visualization 
Intraoperative cholangiography
Laparoscopic cholecystectomy (LC) is one of the most
frequently performed surgical procedures worldwide [2, 3].
The most serious complication is bile duct injury with an
incidence 0.3–1.5% [4–6]. Bile duct injury has significant
impact on quality of life and survival. Since the introduc-
tion of LC, prevention of complications has been a priority
of surgeons [7]. To avoid complications such as bile duct
injury, instruments have been developed to minimize risk.
One of the strategies is the critical view of safety (CVS)
during the dissection of the gallbladder according to
Strasberg [8].
Despite introduction of CVS, the use of modern high-
resolution cameras and angled optics, the incidence of bile
duct injury still remains 0.42% [9]. Most common causes
of bile duct injury are poor identification of the biliary tract
and inflammatory changes such as acute cholecystitis. To
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overcome risk of bile duct injury, extra intraoperative
visualization techniques, such as intraoperative ultrasound
and cholangiogram (IOC), have been introduced [10].
IOC is a technique that aids the surgeon to identify the
biliary anatomy, possible common bile duct stones and
anatomical variations during LC. The use of IOC is
debateable. Advocates of the technique argue IOC should
be used routinely during LC in order to avoid bile duct
injury. Adversaries argue that the technique is not practi-
cally feasible, because additional trained staff is required
during surgery [5]. Furthermore, incision of the cystic duct
is required which could lead to possible bile duct injury.
Also, IOC provides additional harmful radiation for the
patient [5, 11, 12]. Another disadvantage is that partial
dissection of Calot’s triangle should be performed before
IOC can be utilized and, therefore, bile duct injury can
occur before IOC.
Recently, intraoperative visualization of the bile ducts
using near-infrared light and the fluorescent dye indocya-
nine green (ICG) were introduced during cholecystectomy
[13]. This technique provides real-time imaging of the
biliary tract even before dissection of Calot’s triangle.
ICG is an intravenously delivered agent, which when
stimulated by near-infrared light (700–900 nm) provides
fluorescent visualization of vascular and biliary structures.
ICG is a water-soluble dye with peak spectral absorption at
800 nm. After intravenous injection, ICG is bound to
plasma proteins and, therefore, remains intravascular. ICG
is metabolized almost exclusively by hepatic parenchymal
cells and secreted into the bile. Peak concentration in the
bile occurs between 30 min and 2 h after injection,
whereas peak concentration in the arterial system is
reached within 1–2 min [14].
Near-infrared imaging with ICG during LC has only
recently been introduced [15, 16]. Under near-infrared
light, the biliary structures are fluorescently highlighted,
potentially aiding anatomical identification and prevention
of bile duct injury. Benefits of ICG include that it is less
invasive and no incision of the cystic duct is required, nor
is the patient exposed to radiation. Furthermore, ICG has
the potential to identify the biliary tract before dissection of
Calot’s triangle, whereas IOC is generally performed after
dissection of the CD.
Currently, near-infrared imaging with ICG is rapidly
expanding to other surgical areas. The use of near-infrared
imaging with ICG for LC is suggested to be safe and
feasible [17–19]. However, between the published studies
there is wide variation in technical and procedure-related
factors, such as dosage, timing of ICG administration and
patient pathology.
Primary question of this systematic review is to evaluate
how the near-infrared imaging technique with ICG is used
during LC in order to identify biliary structures. Secondary
questions include: what is the influence of dosage and
timing on biliary tract visualization before and after dis-
section of Calot’s triangle? What is the influence of obesity
and gallbladder disease aetiology on biliary tract visual-
ization? And does near-infrared imaging with ICG provide
more frequent biliary tract visualization compared to IOC?
Methods
This systematic review was conducted in accordance with
the preferred reporting items for systematic reviews and
meta-analysis statement [20]. No approval of the medical
ethics committee was required.
Criteria for considering studies for this review
Eligibility criteria
Articles were included if they fulfilled the following cri-
teria: (1) the study describes the use of near-infrared
imaging with ICG; (2) reports on laparoscopic cholecys-
tectomies in humans for treatment of gallbladder disease
(e.g. cholecystolithiasis and cholecystitis); and (3) used a
prospective design (i.e. cohort study or randomized con-
trolled trial). To avoid overlapping patient data in duplicate
publications, the article with the largest sample size was
included. No publication date or publication status
restrictions were imposed. Only studies published in Eng-
lish, German or Dutch were included.
Types of outcome measures
Primary outcome of this review was extrahepatic biliary
tract visualization of the cystic duct [1], common bile duct
(CBD) and common hepatic duct (CHD) before and after
dissection of Calot’s triangle. Secondary outcomes were
comparison of ICG to IOC, dosage and timing of admin-
istration of ICG and body mass index (BMI).
Search methods for selection of studies
Electronic searches
A comprehensive search was performed in the biblio-
graphic databases PubMed, Embase.com, the Cochrane
Library (via Wiley) and Web of Science from inception of
the databases to the 8 February 2016, in collaboration with
a medical librarian (LS). Search terms included controlled
terms (Mesh in PubMed, Emtree in Embase) as well as free
text terms. Free text terms were only used in the Cochrane
Library and Web of Science. The following terms were
used (including synonyms and closely related words) as
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index terms: ‘biliary tract surgical procedures’ or ‘biliary
tract’ or ‘biliary tract diseases’ and ‘cholangiography’ or
‘spectroscopy’ or ‘near-infrared’ or ‘surgery, computer-
assisted’ and ‘indocyanine green’ or ‘fluorescent dyes’.
The full search strategies for all the databases are given in
‘‘Supplementary Information S1’’.
Searching other sources
Systematic reviews and narrative review articles that were
identified during the search were checked for additional
references.
Data collection and analysis
Selection of studies
Article selection was performed by three authors inde-
pendent of one another (DvD, SV and MA). Titles and
abstracts were first screened, and when unclear, the full text
of an article was examined. In case of disagreement
regarding inclusion or exclusion, a paper was discussed to
establish consensus. To avoid overlapping patient data in
duplicate publications, the article with the largest sample
size was included. The process of inclusion is shown in a
flow chart (Fig. 1).
Data extraction and management
Data were extracted by three authors (SV, DvD and MA)
independent of one another using a data extraction form
that included information on: publication details; dosage
and timing of ICG administration; camera system used;
general patient characteristics; general surgical procedure
characteristics, including conversion and complication rate
and operating time; LC indications and information on
biliary tract visualization.
Risk of bias assessment
Two authors (SV and MA) assessed the risk of bias for
studies that reported comparisons between ICG and IOC
using the Cochrane’s ROBINS-I tool (Risk Of Bias In Non-
randomized Studies of Interventions) [21]. The following
items were assessed: bias due to confounding; selection
bias; bias in measurement of interventions; bias due to
missing data; bias in measurement of outcomes; and bias in
the selection of the reported result. Each domain was
scored as low, moderate, serious or critical risk of bias.
Overall risk of bias of the included study was scored
serious if serious risk of bias was scored in at least one
domain. If no serious risk of bias was scored in any
domain, the study would receive an overall moderate risk
of bias.
Measures of treatment effect
The primary outcome is dichotomous (i.e. identification
biliary structure). Prevalence of biliary duct visualization
for the CD, CBD, CHD and the cystic duct junction (CD-j)
is given as proportions. Weighted mean biliary duct visu-
alization was calculated through pooled analysis in a ran-
dom effects model with 95% confidence intervals using
MedCalc software (Oostende, Belgium).
ICG visualization was compared to IOC for the CD,
CBD and CHD. Outcomes are weighted by inverse vari-
ance in a random effects model. Treatment effect is pre-
sented as relative risk with 95% confidence intervals. These
analyses were conducted in RevMan5 [22]. Heterogeneity
between studies was assessed through a number of man-
ners: Eye-Ball, Q test and the I2 statistic. Technical failure
of IOC was not excluded from calculations, but analysed as
not able to visualize the bile duct structures.
Data synthesis
The overall quality of the evidence and strength of rec-
ommendations was evaluated using GRADE [23]. At the
start of GRADE assessment process, we assumed high
quality for all studies and we downgraded the quality of the
evidence for each comparison by one to two levels
depending on the seriousness of the violations in each
domain.
To assess the risk of bias for a comparison, the risk of
bias tables for each study in that comparison was consid-
ered. For each comparison, the risk of bias was considered
serious (-1) if a majority of the evidence in the studies
included in the meta-analysis (in terms of number of par-
ticipants) scored serious risk of bias. For consistency, we
considered a majority of the following four items: an I2
value of more than 50%, statistical significance of hetero-
geneity (p\ 0.05), large variation in size effect and no
overlapping of confidence intervals for downgrading (-1).
If half of the items were scored for inconsistency, the
variation in size effect and confidence intervals were con-
sidered decisive. For imprecision of results, serious
imprecision leading to downgrading (-1) was judged if a
comparison included fewer than 22,000 participants or if
wide confidence intervals around the effect estimate were
reported. Indirectness of the evidence was not an issue in
this review, because the population, intervention, compar-
ison and outcomes were directly correlated with the review
question. Summary of Findings tables were generated for
the primary analyses and for the primary outcome mea-
sures only. The quality of the evidence is described as:
Surg Endosc (2017) 31:2731–2742 2733
123
• High: further research is very unlikely to change our
confidence in the estimate of effect;
• Moderate: further research is likely to have an impor-
tant impact on our confidence in the estimate of effect
and may change the estimate;
• Low: further research is very likely to have an
important impact on our confidence in the estimate of
effect and is likely to change the estimate.
• Very low: the true effect is likely to be substantially
different from the estimate of effect.
Fig. 1 PRISMA—flowchart of search strategy (8 February 2016)
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A ‘Summary of Findings’ table was created using
GRADEpro software [24].
Results
An overview of included studies is provided in Table 1. In
total, 19 studies were included for qualitative evaluation.
Of 19 studies [15, 16, 25–41], one non-randomized con-
trolled trial was identified [27] and 18 prospective cohort
studies. In total, 772 patients were reported, with a 0.5% (1/
197 patients) conversion rate and 1.7% (10/578 patients)
complication rate.
Of 19 studies, 13 reported near-infrared imaging with
ICG during laparoscopic cholecystectomy [15, 16, 25,
28–30, 33–37, 40, 41] and six studies reported multiple
laparoscopic techniques, including single incision and
robotic surgery [26, 27, 31, 32, 38, 39].
Average time of first ICG administration varied between
74 min prior to surgery up to after tracheal intubation.
Most studies administered ICG between 45 and 60 min
prior to surgery. Timing of a second administration was
reported on different moments during the surgical proce-
dure in order to identify the cystic artery (CA). The CA
was identified in 85.9% [SD 8.33] of the cases [32, 34, 37].
For near-infrared visualization, the use of six different
camera systems has been reported.
In total, 14 studies included patients with only uncom-
plicated gallbladder disease (cholecystolithiasis, chronic
cholecystitis or gallbladder polyp), encompassing 311
patients [15, 16, 26, 27, 30–32, 35, 37–41], and five studies
included both complicated and uncomplicated gallbladder
disease (acute cholecystitis, biliary pancreatitis, cholestasis
and post-ERCP), encompassing 461 patients [25, 28,
29, 33, 34]. In total, 78 of 461 patients suffered compli-
cated gallbladder disease.
Biliary tract visualization per dosage of ICG
Several dosage schemes were used: a fixed dosage of
2.5 mg ICG was used in nine studies [16, 26, 27, 31, 33,
35, 37–39], a dosage of 0.05 mg/kg bodyweight was used
in six studies [28–30, 32, 34, 40], a dosage of 0.5 mg/kg
bodyweight was used in two studies [25, 36] and two
studies reported other dosage schemes [15, 41]. For anal-
ysis of biliary tract identification, the studies providing
information on dosage scheme were stratified by fixed
dosage (2.5 mg) and dosage per kilogram bodyweight
(0.05 mg/kg) as given in Table 2.
Seven studies were stratified to the fixed dosage group
encompassing 336 patients [16, 26, 31, 33, 35, 37, 38]. Six
studies were stratified to the 0.05 mg/kg bodyweight group
encompassing 274 patients [28–30, 32, 34, 40]. One study
reported on visualization of the CD-j before dissection with
positive identification in 35 of 35 cases [34]. No studies
reported on the CHD and CD-j visualization after dissec-
tion. Two studies have used a dosage scheme of 0.5 mg/kg
bodyweight, of which one has evaluated visualization of the
biliary structures before and after dissection in 23 patients
[36]. Two included studies with different dosage schemes
[15, 41] did not report on biliary tract visualization.
In addition to the CD, CBD, CHD, other structures or
aberrant anatomy were identified in 70/772 (9.1%) of the
patients. Mostly, the confluence of the right and left hepatic
duct was visualized [16, 30, 34]. Other identified structures
include: an extra CA [40], additional hepatic duct or aberrant
course of the CD [16, 30, 34, 40] and a CBD cyst [30].
ICG versus IOC visualization
In total, four studies compared the use of ICG with IOC in
215 patients [29, 30, 35, 36]. Risk of bias was scored
moderate for visualization of the CD and CBD and serious
for visualization of the CHD (Table 3). Results of biliary
structure visualization with ICG and IOC are presented in
Fig. 2A–C. There is moderate quality evidence that visu-
alization of the cystic duct with ICG is better than using the
IOC (RR 1.16; 95% CI 1.00–1.35), and, respectively,
moderate and low quality evidence for the visualization of
the CBD (RR 1.00; 95% CI 0.97–1.03) and CHD (RR 0.76;
95% CI 0.58–1.01)with ICG compared to visualization
with IOC. None of the estimated effect sizes were statis-
tically significant (Table 4). All three comparisons were
downgraded for serious imprecision because few partici-
pants were examined. The comparison of the CHD also
scored serious risk of bias due to possible selection bias.
Obesity and visualization accuracy
In addition to using BMI as a baseline characteristic, three
studies reported on ICG visualization in different BMI
groups [27, 28, 35]. Osayi et al. [35] reported similar
visualization rates for the CD, CBD and CHD, but signif-
icantly increased visualization of the CD junction in the
BMI B 30 group (p = 0.038). Analysis of 20 patients with
BMI[ 35 revealed prevalence of visualization of the CD
and CBD of 91 and 64%. Dip et al. [28] evaluated 71
patients of whom 53% had a BMI[ 30. They reported no
statistically significant differences between obese
(BMI[ 30) and non-obese (BMI B 30) patients for biliary
tract visualization. Obesity was mentioned as a cause of
failure of ICG visualization of bile ducts in one study [15].
Buchs et al. [27] noted a significant faster dissection in
the ICG group compared to the control group (conventional
laparoscopy) in patients with a BMI\ 25. Biliary tract
visualization was not assessed.
Surg Endosc (2017) 31:2731–2742 2735
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Discussion
This systematic review has examined the use of near-in-
frared imaging using ICG for visualization of the cystic
duct and related structures. Results suggest that the use of
the near-infrared imaging with ICG technique provides
good overall visualization rates of the CD, CBD, CHD and
CD junction prior to and following dissection of Calot’s
triangle. Although the number of studies is limited and,
therefore, the strength of our conclusions is also limited,
visualization rates of the biliary structures using near-in-
frared imaging techniques with ICG appear to be equally
good for either 2.5 mg fixed dosage or 0.05 mg per kg
dosage of ICG. Small variation of timing of ICG
Table 2 Biliary tract visualization per dosage scheme
Study n Adm. timing
(mins)
CD before CD after CBD before CBD after CHD before CHD after
Biliary tract visualization with a 2.5-mg fixed dosage of ICG n (%)
Ishazawa
[16]
52 30 52 (100) 52 (100) – – 50 (96.2) 52 (100)
Ishazawa
[31]
7 15a 5 (71.4) – – – 7 (100) –
Buchs [26] 12 45 11 (91.7) 12 (100) 6 (50) 10 (83.3) 4 (33.3) 8 (66.7)
Schols [37] 30 15a 29 (96.7) – 25 (83.3) – – –
Spinoglio
[38]
45 45 42 (93.3) 44 (97.8) 41 (91.1) 44 (97.8) 40 (88.9) 44 (97.8)
Osayi [35] 82 74 46 (56.1) 78 (95.1) 31 (37.8) 63 (76.8) 29 (35.4) 57 (69.5)
Kono [33] 108 – 88 (81.5) 103 (95.4) – 94 (87.0) 100 (92.6)
Weighted mean % (95% CI) 86.5
(71.2–96.6)
96.5
(93.9–98.4)
67.3
(35.5–92.1)
86.6
(67.1–98.0)
76.8
(51.2–94.7)
88.9
(73.5–98.2)
Biliary tract visualization with a 0.05-mg per kg bodyweight dosage of ICG n (%)
Kaneko [32] 28 15 26 (92.8) – – – 27 (96.4) –
Dip [30] 65 60 50 (76.9) 65 (100) 50 (76.9) 65 (100) – –
Dip [29] 45 60 44 (97.8)b – 36 (80.0)b – 27 (60.0)b –
Larsen [34] 35 15a – – – – – –
van Dam
[40]
30 15a 10 (33.3) 29 (96.7) 20 (66.7) 26 (86.7) – –
Dip [28] 71 60 71 (100) – 62 (87.3) – 50 (70.4) –
Weighted mean % (95% CI) 85.2
(60.2–98.9)
98.4
(92.4–99.9)
78.7
(70.3–86.0)
95.3
(73.4–99.0)
76.6
(54.5–92.9)
Visualization per dosage group. Number of biliary structure identifications n (% proportion) before and after dissection of Calot’s triangle.
Timing of ICG administration is equal (average 37.3 and 37.5 min before surgery) for both groups
ICG indocyanine green, timing timing of administration, mins minutes, CD cystic duct, CBD common bile duct, CHD common hepatic duct
a ICG administration after anaesthesia
b Biliary structure identification before and during dissection
Table 3 Risk of bias,
ROBINS-I
ROBINS-I Dip [30] Dip [46] Osayi [35] Prevot [36]
Participants 65 45 82 23
Domain
Bias due to confounding Low Low Low Low
Bias in selection of participants into the study Low Low Serious Serious
Bias in measurement of interventions Low Low Low Low
Bias due to departures from intended interventions Low Low Low Low
Bias due to missing data Low Low Low Low
Bias in measurement of outcomes Moderate Moderate Moderate Moderate
Bias in selection of the reported result Low Low Low Low
Overall Moderate Moderate Serious Serious
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administration was seen, varying between over an hour
before surgery until directly after anaesthesia. As of yet,
studies have revealed little information regarding influence
of obesity or gallbladder disease aetiology on biliary tract
visualization. Also, biliary tract visualization was compa-
rable for near-infrared imaging with ICG and conventional
IOC.
Most studies used similar timing of ICG administration.
Only Kono et al. [33] described in their cohort a difference
in visualization of the CD-j after different administration
times, with significantly more CD-j visualization after a
longer preoperative administration of ICG (median 90 min
prior to surgery (range 15–165) versus 47 min (range
21–205), p\ 0.01). Verbeek et al. [41] described that
administration of ICG 24 h prior to surgery results in a
significantly increased CBD-to-liver contrast. Longer pre-
operative administration of ICG could result in increased
visualization rates of the biliary tract structures.
An important factor that could influence ICG imaging is
the amount of intra-abdominal adipose tissue. Unfortu-
nately, too few studies have examined this aspect and;
therefore, strong conclusions cannot be derived. Interest-
ingly, one study [35] reported improved visualization rates
for the CD-j in patients with lower BMI, while another
study reported no differences [28] with increasing BMI.
Intra-abdominal adipose tissue has been known to be a risk
factor in abdominal surgery, leading to increased number
of post-operative complications [42]. More intra-
Fig. 2 A Meta-analysis of CD visualization. ICG versus IOC. BMeta-analysis of CBD visualization. ICG versus IOC. C Meta-analysis of CHD
visualization. ICG versus IOC
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abdominal adipose tissue results in a decreased penetration
of near-infrared light and thus decreased visualization of
biliary tract structures [33]. BMI has been used as a stan-
dard for obesity because of its simplicity; however, BMI
does not distinguish between the type of adipose tissue or
location of fat within the intra-abdominal cavity [43, 44].
In order to assess the effects of intra-abdominal adipose
tissue on near-infrared imaging with ICG, the patients
should be selected on basis of fat percentage assessed by
either CT or MRI instead of BMI [45].
There is moderate quality evidence comparing near-in-
frared imaging using ICG to conventional IOC; therefore,
future research is likely to have an important impact on
confidence in the estimate of effect and may change the
estimate. However, since IOC comes with higher costs,
more difficult perioperative logistics, greater radiation
exposure, greater use of radiographic contrast fluids, fre-
quent technical failure and risk of bile duct injury due to
cannulation of the CD, ICG might be considered to be the
better option for visualization of the biliary tract [46],
although further research is necessary to confirm this
recommendation.
As IOC depends on at least partial dissection in order to
cannulate the CD, ICG provides early imaging before start
of dissection. Not only are early (prior to dissection)
identification rates with ICG adequate, ICG can be used
multiple times during dissection without increasing radia-
tion or contrast load to the patient compared to IOC. Also,
Table 4 GRADE summary of evidence
ICG compared to IOC for identification of the biliary ducts Patient or population: identification of the biliary ducts
Setting: VU University Medical Centre
Intervention: ICG
Comparison: IOC
Outcomes Anticipated absolute
effects* (95% CI)
Relative effect
(95% CI)
No. of participants
(studies)
Quality of the
evidence [22]
Comments
Risk with IOC Risk with ICG
Cystic duct Study population RR 1.16
(1.00–1.35)
430 (four
observational
studies)
Moderatea,b,c,d,e Downgraded for imprecision
837 per 1000 971 per 1000
(837–1000)
Common bile
duct
Study population RR 1.00
(0.97–1.03)
430 (four
observational
studies)
Moderatee,f Downgraded for imprecision
851 per 1000 851 per 1000
(826–877)
Common
hepatic duct
Study population RR 0.76
(0.58–1.01)
300 (three
observational
studies)
Lowb,e,f,g Downgraded for imprecision and
serious risk of bias
793 per 1000 603 per 1000
(460–801)
*The risk in the intervention group (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect
of the intervention (and its 95% CI)
CI: Confidence interval; RR: risk ratio
GRADE Working Group grades of evidence
High quality: we are very confident that the true effect lies close to that of the estimate of the effect
Moderate quality: we are moderately confident in the effect estimate that the true effect is likely to be close to the estimate of the effect, but there
is a possibility that it is substantially different
Low quality: our confidence in the effect estimate is limited that the true effect may be substantially different from the estimate of the effect
Very low quality: we have very little confidence in the effect estimate that the true effect is likely to be substantially different from the estimate
of effect
a Test for heterogeneity p\ 0.0001
b I2[ 50%
c Small variation in size effect
d Overlapping of CI
e Two studies (Osayi/Prevot) include only patients with uncomplicated gallbladder disease
f CI crosses clinical decision threshold
g Selection bias
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overall costs for ICG are 32.3 USD compared to 778.83
USD for IOC [46], although cost for the near-infrared
imaging system is unclear.
Several studies have reported aberrant biliary anatomy
with the use of ICG [16, 30, 34, 40]. Most commonly
reported aberrant anatomy are variations in the hepatic duct.
Failure to identify aberrant biliary anatomy could result in
bile duct injury. In order to reduce major post-operative
complications, ICG identification of aberrant anatomymight
lead to a reduced rate of biliary tract leakages.
This systematic review is limited by the design of the
included studies. Most included studies are prospective
cohort studies and, therefore, highly subject to bias. To date,
no randomized trials have been performed that investigate
biliary tract visualization. The design of these prospective
cohort studies is also limited because most studies did not
compare intraoperative visualization with ICG to conven-
tional white light laparoscopy. Therefore, no conclusions
can be drawn whether the near-infrared with ICG technique
provides advantages over conventional laparoscopy.
In addition, a rather heterogeneous population was
examined. Some studies included only uncomplicated
gallbladder disease, while others have included both
complicated and uncomplicated disease. In the studies
reporting both indications, biliary tract visualization results
for both complicated and uncomplicated are pooled toge-
ther. Furthermore, studies used different definitions for
uncomplicated and complicated gallbladder disease.
Therefore, no conclusions can be drawn on the use of
biliary tract visualization for either complicated or
uncomplicated gallbladder disease.
This systematic review and meta-analysis emphasize the
need for further investigation. Randomized trials compar-
ing near-infrared imaging with ICG to conventional white
light laparoscopy are needed to assess the additive value of
near-infrared imaging with ICG. Also, the effect of earlier
preoperative ICG administration on biliary tract visual-
ization should be further evaluated. To analyse the effect of
uncomplicated and complicated gallbladder disease on ICG
visualization results, further research should clearly define
included patients groups.
Conclusion
This systematic review shows that near-infrared imaging
with ICG provides good visualization of the biliary struc-
tures during LC. Visualization rates were equal for both
dosage schemes. When compared to IOC, ICG provides
equal visualization of the bile ducts before dissec-
tion. Near-infrared imaging with ICG has the potential to
replace IOC for biliary mapping. However, future research
is necessary for optimization and standardization of the
near-infrared ICG technique.
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